Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00978848
Other study ID # PRO8120077
Secondary ID
Status Completed
Phase N/A
First received September 16, 2009
Last updated May 17, 2016
Start date November 2009
Est. completion date April 2010

Study information

Verified date May 2016
Source University of Pittsburgh
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine the prevalence and treatment rates of T. vaginalis, C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy testing in the Magee-Womens Hospital outpatient clinic using a non-invasive urine STD test.


Description:

This study has three primary objectives: 1) to determine the prevalence of T. vaginalis, C. trachomatis, and N. gonorrhoeae in women seeking emergency contraception or urine pregnancy testing - a population likely at increased risk of acquiring STDs; 2) to determine the rate of successful treatment in women diagnosed with STDs in this venue.


Recruitment information / eligibility

Status Completed
Enrollment 305
Est. completion date April 2010
Est. primary completion date April 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 15 Years and older
Eligibility Inclusion Criteria:

- Females at least age 15 at time of enrollment who are presenting at Magee-Womens Hospital for emergency contraception or urine pregnancy testing.

- Ability to provide written informed consent.

Exclusion Criteria:

- Diagnosis and/or treatment for an STD within 4 weeks of enrollment in the study.

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Locations

Country Name City State
United States Magee-Womens Hospital of UPMC Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pittsburgh Gen-Probe, Incorporated

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Completed NCT03676816 - Self Sampling for Rapid Turnaround Testing in the Emergency Department N/A
Completed NCT00213018 - Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission Phase 2
Completed NCT00827970 - Randomized Population-Based Study on Chlamydia Trachomatis Screening N/A
Completed NCT01733069 - Clinical Evaluation of the APTIMA® COMBO 2® Assay Using the PANTHER™ System N/A
Withdrawn NCT01358799 - Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System N/A
Completed NCT02391233 - Multimedia WORTH With Black Drug-Involved Women on Probation N/A
Completed NCT00973466 - Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients N/A
Completed NCT03071510 - Evaluation of the Atlas Genetics io® CTNG System
Recruiting NCT04446611 - Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes N/A
Completed NCT01329588 - Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers Phase 4
Not yet recruiting NCT06216964 - Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study N/A
Terminated NCT02795975 - Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples N/A
Completed NCT00213057 - Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand Phase 1
Completed NCT00207454 - Optimizing Strategies to Improve STD Partner Services Phase 1
Completed NCT00177437 - Home Screening for Chlamydia Surveillance Phase 3
Completed NCT02787109 - Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years Phase 1
Completed NCT01665690 - Washington State Community Expedited Partner Treatment (EPT) Trial Phase 4
Completed NCT02128620 - A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour N/A
Completed NCT00618449 - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Phase 4
Recruiting NCT01661985 - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Phase 4